Lisata Therapeutics, Inc. (LSTA)
3.25
-0.05
(-1.52%)
USD |
NASDAQ |
May 29, 16:00
4.18
+0.93
(+28.62%)
After-Hours: 20:00
Lisata Therapeutics EPS Diluted (Quarterly) : -0.4984 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -0.4303 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.489M |
| Total Expenses (Quarterly) | 4.489M |
| Enterprise Value | 16.28M |
| Earnings Yield | -57.25% |
| Normalized Earnings Yield | -57.25 |